Adam Scott Levy, CFO and Secretary at Mineralys Therapeutics, Inc. (MLYS), sold 21,516 shares at $14.45 ($311K) on 2025-07-11, disclosed to the SEC on 2025-07-15.
Scheduled sale ($311k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.45 | 10,758 | $155K | 50.0% |
| 2 | $14.45 | 10,758 | $155K | 50.0% |
| Total | $14.45 avg | 21,516 | $311K | 100% |
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-04-15 | $259K | — | Filing → |